|
Volumn 62, Issue 5, 2006, Pages 361-366
|
Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus
|
Author keywords
Cyclosporine; Drug interaction; Sirolimus
|
Indexed keywords
CYCLOSPORIN;
CYCLOSPORIN A;
GENERIC DRUG;
RAPAMYCIN;
ADULT;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
BIOEQUIVALENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CAPSULE;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG SOLUTION;
DRUG SUBSTITUTION;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NONHUMAN;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
ADULT;
AGED;
ANALYSIS OF VARIANCE;
ANIMALS;
AREA UNDER CURVE;
CHEMISTRY, PHARMACEUTICAL;
CROSS-OVER STUDIES;
CYCLOSPORINE;
DOGS;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
DRUGS, GENERIC;
FASTING;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
PRESCRIPTIONS, DRUG;
SIROLIMUS;
THERAPEUTIC EQUIVALENCY;
TIME FACTORS;
|
EID: 33646535088
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s00228-006-0109-z Document Type: Article |
Times cited : (16)
|
References (10)
|